Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Six existing drugs may help block virus entry in COVID-19.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Skin and mucosal issues can occur after COVID-19 in adults and children.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

Avacopan may cause unexpected side effects, so early monitoring is important.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

AGA might indicate higher risk for severe COVID-19.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Cepharanthine shows promise as a COVID-19 treatment.

Children with chilblain-like lesions may have a link to COVID-19.

A new delivery system makes Curcumin more effective and safer against viruses.

COVID-19 causes more taste, smell, hair, memory, and concentration issues than other respiratory infections.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.